MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on November 7, 2007; DOI: 10.1124/mol.107.039743


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.107.039743v1
73/2/359    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zou, S.
Right arrow Articles by Dryer, S. E
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zou, S.
Right arrow Articles by Dryer, S. E


Received for publication July 6, 2007.
Revised November 6, 2007.
Accepted for publication November 7, 2007.

A novel actin-binding domain on Slo1 calcium-activated potassium channels is necessary for their expression in the plasma membrane

Shengwei Zou 1, Smita Jha 1, Eun Young Kim 1, Stuart E Dryer 1*

1 University of Houston

* Address correspondence to: E-mail: sdryer{at}uh.edu

Abstract

Large-conductance Ca2+-activated K+ (BKCa) channels regulate the physiological properties of many cell types. The gating properties of BKCa channels are Ca2+-, voltage- and stretch-sensitive, and stretch-sensitive gating of these channels requires interactions with actin microfilaments subjacent to the plasma membrane. However, trafficking of BKCa channels to the plasma membrane has been associated with processes that alter cytoskeletal dynamics. Here we show that the Slo1 subunits of BKCa channels contain a novel cytoplasmic actin-binding domain (ABD) close to the C-terminal, considerably downstream from regions of the channel molecule that play a major role in determining channel gating properties. Actin binding to the ABD can occur in a binary mixture in the absence of other proteins. Co-expression of a small ABD-GFP fusion protein that competes with full-length Slo1 channels for binding to actin markedly suppresses trafficking of full-length Slo1 channels to the plasma membrane. In addition, Slo1 channels containing deletions of the ABD that eliminate actin binding are retained in intracellular pools and are not expressed on the cell surface. At least one point mutation within the ABD (L1020A) reduces surface expression of Slo1 channels to about 25% of wild-type, but does not cause a marked effect on the gating of point mutant channels that reach the cell surface. These data suggest that Slo1-actin interactions are necessary for normal trafficking of BKCa channels to the plasma membrane, and the mechanisms of this interaction may be different from those that underlie F-actin and stretch-sensitive gating.


Key words: Ion channel regulation, Func. analysis receptor/ion channel mutants, Immunocytochemistry, Mutagenesis/Chimeric approaches


This article has been cited by other articles:


Home page
Am. J. Physiol. Renal Physiol.Home page
E. Y. Kim, K.-J. Choi, and S. E. Dryer
Nephrin binds to the COOH terminus of a large-conductance Ca2+-activated K+ channel isoform and regulates its expression on the cell surface
Am J Physiol Renal Physiol, July 1, 2008; 295(1): F235 - F246.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2007 by the American Society for Pharmacology and Experimental Therapeutics